TRADING UPDATES: GetsBusy backs sales outlook; Cizzle raises funds
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Price | 1.40p on 08-08-2025 | at 18:50:05
---|---|
Change | 0.00p 0% |
Buy | 1.50p |
Sell | 1.30p |
Last Trade: | Sell 18,680.00 at 1.326p |
Day's Volume: | 2,519,282 |
Last Close: | 1.40p |
Open: | 1.40p |
ISIN: | GB00BNG2VN02 |
Day's Range | 1.30p - 1.40p |
52wk Range: | 1.25p - 2.65p |
Market Capitalisation: | £5.55m |
VWAP: | 1.36145p |
Shares in Issue: | 396.39m |
Sector: Medicine and Biotech
Cizzle Biotech (CIZ) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 18,680 | 1.326p | Ordinary |
15:14:27 - 08-Aug-25 |
Buy* | 177,434 | 1.40p | Ordinary |
14:55:45 - 08-Aug-25 |
Buy* | 177,434 | 1.40p | Ordinary |
14:55:24 - 08-Aug-25 |
Sell* | 141,571 | 1.275p | Ordinary |
14:14:36 - 08-Aug-25 |
Sell* | 83 | 1.20p | SI Trade |
13:55:55 - 08-Aug-25 |
Sell* | 229,886 | 1.305p | Ordinary |
12:35:44 - 08-Aug-25 |
Buy* | 133 | 1.50p | Ordinary |
11:36:16 - 08-Aug-25 |
Buy* | 663 | 1.50p | Ordinary |
08:50:56 - 08-Aug-25 |
Sell* | 53,493 | 1.374p | Ordinary |
08:23:27 - 08-Aug-25 |
Sell* | 233,624 | 1.374p | Ordinary |
08:01:18 - 08-Aug-25 |
Cizzle Biotech (CIZ) Regulatory News |
||
Date | Source | Headline |
---|---|---|
30th Jun 2025 1:45 pm | RNS | Result of AGM |
6th Jun 2025 11:00 am | RNS | Notice of AGM |
28th May 2025 7:00 am | RNS | Holding(s) in Company |
20th May 2025 7:00 am | RNS | £150,000 Convertible Loan Note Issue |
30th Apr 2025 11:18 am | RNS | Final results for the year ended 31 December 2024 |
28th Apr 2025 7:00 am | RNS | Contract in Caribbean and Update on CIZ1B |
14th Apr 2025 10:00 am | RNS-R | Launch of New Website |
25th Mar 2025 7:00 am | RNS | Appointment of Non-Executive Director |
24th Mar 2025 7:00 am | RNS | Update on Launch of CIZ1B Biomarker Assay |
2nd Jan 2025 7:00 am | RNS | Appointment of Professor Dawn Coverley as CSO |